| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30064714 | HIV | ENSG00000112062.13 | protein_coding | MAPK14 | No | No | 1432 | B4E0K5 L7RSM2 Q16539 |
| TVIS30064715 | HIV | ENSG00000112062.13 | protein_coding | MAPK14 | No | No | 1432 | B4E0K5 L7RSM2 Q16539 |
| TVIS30064716 | HIV | ENSG00000112062.13 | protein_coding | MAPK14 | No | No | 1432 | B4E0K5 L7RSM2 Q16539 |
| TVIS30064717 | HIV | ENSG00000112062.13 | protein_coding | MAPK14 | No | No | 1432 | B4E0K5 L7RSM2 Q16539 |
| TVIS30064718 | HIV | ENSG00000112062.13 | protein_coding | MAPK14 | No | No | 1432 | B4E0K5 L7RSM2 Q16539 |
| TVIS30064719 | HIV | ENSG00000112062.13 | protein_coding | MAPK14 | No | No | 1432 | B4E0K5 L7RSM2 Q16539 |
| TVIS30064720 | HIV | ENSG00000112062.13 | protein_coding | MAPK14 | No | No | 1432 | B4E0K5 L7RSM2 Q16539 |
| TVIS30064721 | HIV | ENSG00000112062.13 | protein_coding | MAPK14 | No | No | 1432 | B4E0K5 L7RSM2 Q16539 |
| TVIS30064722 | HIV | ENSG00000112062.13 | protein_coding | MAPK14 | No | No | 1432 | B4E0K5 L7RSM2 Q16539 |
| TVIS30064723 | HIV | ENSG00000112062.13 | protein_coding | MAPK14 | No | No | 1432 | B4E0K5 L7RSM2 Q16539 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | MAPK14 |
|---|---|
| DrugBank ID | DB01254 |
| Drug Name | Dasatinib |
| Target ID | BE0001019 |
| UniProt ID | Q16539 |
| Regulation Type | binder |
| PubMed IDs | 18180381 |
| Citations | Kneidinger M, Schmidt U, Rix U, Gleixner KV, Vales A, Baumgartner C, Lupinek C, Weghofer M, Bennett KL, Herrmann H, Schebesta A, Thomas WR, Vrtala S, Valenta R, Lee FY, Ellmeier W, Superti-Furga G, Valent P: The effects of dasatinib on IgE receptor-dependent activation and histamine release in human basophils. Blood. 2008 Mar 15;111(6):3097-107. doi: 10.1182/blood-2007-08-104372. Epub 2008 Jan 7. |
| Groups | Approved; Investigational |
| Direct Classification | Aromatic anilides |
| SMILES | CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1 |
| Pathways | Dasatinib Inhibition of BCR-ABL |
| PharmGKB | PA162372878 |
| ChEMBL | CHEMBL1421 |
